# Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy

> **NCT00740142** · PHASE4 · COMPLETED · sponsor: **Mahidol University** · enrollment: 35 (actual)

## Conditions studied

- Hepatic Encephalopathy

## Interventions

- **DRUG:** L-ornithine-L-aspartate and lactulose
- **DRUG:** placebo and lactulose

## Key facts

- **NCT ID:** NCT00740142
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-08
- **Final completion:** 2011-10
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2020-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00740142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00740142, "Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00740142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*